There is a particular kind of silence I have been thinking about all week. Not the quiet of a room, but the quiet of a record. The kind where a document says a thing is finished, closed, accounted for, and the finishing is exactly what hides the person who did not survive it.
I keep coming back to a registry entry that marked a trial complete. Clean word, complete. It reads like a job well done. And somewhere behind it was a boy who died, whose name never made the page. I do not think that was an accident of paperwork. I think it was the paperwork working as designed, the way spin so often does its best work by leaving things out rather than making things up.
That is the thing I want you to carry out of this Sunday. When someone hands you a tidy summary, ask what had to be left out to make it tidy. The cheerful word, the reassuring adjustment, the study that stops just short of the number that would change the story. We read the receipts here because the people writing the press release are counting on you not to.
Autoimmune & Inflammation
Lupus Hits Nine Women for Every Man, and the Reason May Be Hiding in DNA Both Sexes Share
Scientists sequenced more than 1.25 million immune cells and found over 1,000 genetic switches set differently in men and women, with the female side tuned for stronger inflammation. It may help explain why lupus hits nine women for every man.
A Lung Atlas Found 1,000 Autoimmune-Risk Genes That Blood Studies Missed
For two decades, geneticists mapped thousands of autoimmune-risk variants that sat silent in blood cells. A 1.1-million-cell lung atlas shows the effects switch on only in immune cells lodged in tissue.
Investigations
A Chinese Registry Marked the Trial ‘Complete.’ It Never Mentioned the Boy Who Died.
A boy died in a Chinese gene-therapy trial in August 2025. Months later the registry marked the study ‘complete’ and never mentioned him. He is one of three deaths now pulling Congress toward the trial data U.S. drugmakers ship home from China, while American inspectors almost never see the sites th
Canada Went Looking for the Forever Chemicals Nobody Tracks and Found a Dozen of Them in Women’s Blood
Scientists went hunting for the replacement and precursor PFAS almost nobody measures. In Canadian women’s blood they found a dozen of them, riding alongside the ‘banned’ legacy chemicals that still turn up in nearly everyone.
Drugs & FDA
The FDA Is Building an On-Ramp for Medical AI That Can Hallucinate
The FDA has cleared more than 1,000 AI medical devices and not one large language model. Its new discussion paper starts building the pathway for the ones that can make things up, with faster delivery to market named as an agency priority.
A $2.7 Million Gene Therapy, Approved Because Patients Needed Less Cornstarch
Ultragenyx’s Genglycos won accelerated approval on a surrogate: a 31 percent cut in daily cornstarch. But the disease is low blood sugar, and by the company’s own numbers the treated group spent slightly more time below 70 mg/dL, while liver enzymes spiked in 71 percent and every patient needed ster
Cancer
UC Irvine’s ‘Framework’ for Safer CAR-T Is a Hypothesis Essay, Not a Study
The senior author consults for Kite Pharma, whose Yescarta accounted for all 6 grade-5 neurotoxicity deaths in the cited review’s real-world data, the exact harm the paper proposes to treat.
The Cells That Heal Wounds Are Feeding Breast Cancer Its Nerves
University of Oklahoma researchers blocked the protein in mice and triple-negative tumors grew far less. In patients, all they have is a correlation and a drug, already sold for something else, that has never been tried against breast cancer.
Infectious Disease
Arizona State’s AI Flags Healthy People as ‘Weak’ Vaccine Responders Without Reporting How Often It’s Right
Arizona State’s AI sorts roughly one in twenty healthy people into the ‘weak responder’ column. The clinical payoff, in the lead author’s own words, is more doses. Nobody reported how often the model is right.
Eight Infant Macaques Showed No HIV Rebound for a Year. The Third Drug Comes From a Convicted-Fraud Biotech.
OHSU’s triple regimen left no detectable virus in all eight infant macaques a year after treatment stopped, even after the harshest rebound test. Two of the authors hold a financial stake in the company behind the experimental third drug.
Metabolic & Weight
Fluoride and Kids’ Hearts: The Reassuring Study Tested Water Below What US Taps Are Told to Add
Researchers measured fluoride and heart risk in 161 Iranian children, and the main analysis found no significant link. But they drank water below the level US taps are told to add, and a different adjustment flipped the numbers.
The Exercise Paradox: Lousy for Losing Weight, Your Best Bet for Keeping It Off
A study of more than 1,100 people found activity did almost nothing for the pounds they shed, yet it was one of the strongest signals of whether that weight stayed gone.
Brain & Aging
A Brain Clock Says Your Fourth Language Is Worth 13 Years. Nobody’s Published the Proof.
The 13-years-younger figure comes from a conference talk with no paper behind it, and the sturdier study underneath still can’t tell you whether the languages did anything at all.
Banned in 1979, ‘Legacy’ PCBs Are Now Tied to Shorter Telomeres in Children
Dioxin-like PCBs left American factories decades ago and never left children’s bodies. New research traces how they may erode the protective caps on kids’ chromosomes, and may help explain lower cognitive scores.
Nutrition & Food
A PETA-Tied Doctors Group Is Suing to Kill RFK Jr.’s New Food Pyramid
The Physicians Committee says a secret, industry-tied panel redirected the 2025-2030 dietary guidelines. The group crying capture spent years inside PETA’s funding orbit.
Cut the Fiber and Your Gut Bacteria Start Eating Your Own Gut Lining
Princeton isotope tracing found that when fiber runs short, gut bacteria strip protein off the mucus wall and churn out the same toxins that pile up in failing kidneys. Feed them whole plants and the chemistry flips.